XOMA

formerly XOMA Royalty CorporationAcquired

A biotech royalty aggregator

XOMA is a biotech company in Emeryville, United States, founded in 1981.

Employees
11–50
Founded
1981
Business Model
B2B
Website
xoma.com
Acquisition Date
Jul 2026

About

XOMA Royalty Corporation is a biotech royalty aggregator that acquires economic rights to future milestone and royalty payments associated with pre-commercial clinical candidates and commercial therapies. Originally founded in 1981 as a traditional biotechnology company, XOMA made a strategic pivot in 2017 to become a royalty aggregator, leveraging its existing portfolio of licensed antibody assets to build a diversified portfolio of milestone and royalty rights. The company provides biotech firms, universities, and inventors with non-dilutive, non-recourse capital in exchange for contractual rights to future royalties. XOMA operates a capital-efficient model where all R&D costs are borne by development partners and has grown to over 120 royalty assets. In April 2026, Ligand Pharmaceuticals announced its intent to acquire XOMA Royalty.

Exit History

Data from Indexed.vcUpdated
AcquisitionAcquisition by Ligand PharmaceuticalsJul 2026

1 more event

  • IPO1989

Funding, valuations, and company events, with amounts and investors where available.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • DevOps ×1
  • Marketing & SEO ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Acquisitions

Companies in related industries

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

XOMA on Indexed.vc
<a href="https://indexed.vc/companies/xoma"><img src="https://indexed.vc/api/badge/company/xoma" alt="XOMA on Indexed.vc" width="260" height="76" /></a>